内镜逆行阑尾炎治疗用于慢性粪石性阑尾炎
该单中心回顾性研究纳入60例慢性粪石性阑尾炎患者,评估内镜逆行阑尾炎治疗(ERAT)的安全性与疗效。ERAT插管成功率100%,术后腹痛评分显著下降(P < 0.0001),短期不良事件包括腹痛5例(8.3%)和发热2例(3.3%),长期不良事件包括腹痛复发3例(5.0%)和阑尾炎复发2例(3.3%)。阑尾腔狭窄和扭曲是长期不良事件的危险因素。
要点
- ERAT治疗慢性粪石性阑尾炎插管成功率100%,术后腹痛显著改善。
- 短期不良事件以腹痛(8.3%)和发热(3.3%)为主,长期复发率较低。
- 阑尾腔狭窄和扭曲是ERAT后长期不良事件的独立危险因素。
核心结论
- ERAT可能为慢性粪石性阑尾炎提供安全、有效、微创的替代治疗选择。
- 阑尾腔狭窄和扭曲是ERAT后复发的危险因素。
研究设计与样本
- 单中心回顾性研究,纳入2017年12月至2023年6月于复旦大学附属中山医院接受ERAT的连续慢性粪石性阑尾炎患者60例。
- 分析临床病理特征、操作相关参数、不良事件及随访结局。
主要发现
- ERAT插管成功率为100%(60/60)。
- 中位操作时间为15分钟(IQR 12-25分钟)。
- 术后腹痛评分显著降低(P < 0.0001)。
- 短期不良事件:腹痛5例(8.3%)、发热2例(3.3%)。
- 长期不良事件:腹痛复发3例(5.0%)、阑尾炎复发2例(3.3%),中位复发时间5个月(IQR 2-12个月)。
关键数值与推荐
- 阑尾腔狭窄与长期不良事件显著相关(OR 25.000,95%CI 1.114-561.281,P = 0.043)。
- 阑尾腔扭曲与长期不良事件显著相关(OR 12.500,95%CI 1.373-113.806,P = 0.025)。
临床怎么用
- 对于慢性粪石性阑尾炎,ERAT可作为微创治疗选项,尤其适用于不宜或不愿手术者。
- 术前应评估阑尾腔是否存在狭窄或扭曲,以预判复发风险并加强随访。
局限性
- 回顾性单中心设计,样本量有限(60例)。
- 未与抗生素治疗或手术进行对照。
- 需大规模前瞻性研究进一步验证疗效与安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Chronic appendicitis is a condition with chronic abdominal pain or mild attacks of appendicitis, seriously affecting the patient's quality of life. Endoscopic retrograde appendicitis therapy (ERAT) has emerged as a promising, non-invasive treatment for acute uncomplicated appendicitis. Here, we aim to assess the safety and efficacy of ERAT for chronic fecalith appendicitis. METHODS: We retrospectively reviewed the medical records of consecutive patients who underwent ERAT for chronic fecalith appendicitis at Zhongshan Hospital, Fudan University, Shanghai, China between December 2017 and June 2023. Clinicopathological characteristics, procedure-related parameters, AEs, and follow-up outcomes were analyzed. RESULTS: A total of 60 patients were included. ERAT intubation was successfully performed in all patients (100%). The median procedure time was 15 min (IQR, 12-25 min). The postoperative abdominal pain scores were significantly reduced (P < 0.0001). Short-term adverse events included 5 cases of abdominal pain (8.3%) and 2 cases of fever (3.3%). Long-term adverse events included recurrent abdominal pain in 3 cases (5.0%) and recurrent appendicitis in 2 cases (3.3%). The median time to recurrence was 5 months (IQR, 2-12 months). Logistic regression analysis revealed appendiceal stenosis (OR 25.000, 95% CI 1.114-561.281, P = 0.043) and distorted appendix lumen (OR 12.500, 95% CI 1.373-113.806, P = 0.025) as significant risk factors for long-term adverse events. CONCLUSIONS: ERAT may be a safe, effective and minimally invasive alternative approach for chronic fecalith appendicitis. Appendix lumen stenosis and distortion are risk factors of recurrence. Further large-scale prospective studies are necessary to assess the efficacy and safety of ERAT compared with antibiotic therapy and surgery.
引用
- Ma LY, Hu JW, Cai XL, et al. Endoscopic retrograde appendicitis therapy for management of chronic fecalith appendicitis. Surg Endosc. 2024. PMID: 39572426. doi:10.1007/s00464-024-11339-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。